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Previewsto evaluate the monomeric nature of
mPapaya1, the protein was evaluated
using the recent protocol of Costantini
et al. (2012). In this assay, a test protein
(mPapaya1, for example) is fused to the
cytoplasmic end of the endoplasmic
reticulum (ER) membrane protein
CytERM. If the fusion pair homo-oligo-
merizes, the structure of the ER is
changed from a tubular network into a
visible network of organized smooth
ER whorls. Thus, counting the percent-
age of cells with whorls indicates the
level of oligomerization of the test pro-
tein. In this study, 83% of cells with
the mPapaya1 fusion had a tubular ER
morphology, compared to 77% of cells
expressing the monomeric control pro-
tein mEGFP, suggesting that mPapaya1
is essentially monomeric. As further
support for its monomeric nature,
mPapaya1 was fused to multiple part-
ners (histone H2B, connexins, tubulin,
and others) and observed with micro-
scopy, and the fusion was seen to not
interfere with the normal trafficking or
localization of these proteins.
As a final test, the authors evaluated
mPapaya1 as a partner for FRET. This
was important, because one of the
motivations to create mPapaya1 was to
find an alternative yellow FRET acceptor.
To test the response of mPapaya1 in a
FRET assay, the authors created a pro-
teolytically-sensitive mPapaya/mTFP1
fusion. This donor/acceptor pair shouldhave a Fo¨rster radius of 5.1 nm. This
fusion showed a strong FRET signal
and a large decrease in FRET upon acti-
vation of the protease both in vitro and
in vivo. Thus, mPapaya1 should act as
an excellent yellow FRET acceptor for
structural studies or the creation of new
biosensors.
Completely rational protein design has
seen limited success. Perhaps this is the
result of the complex and interconnected
nature of a protein’s structure and func-
tion (Fleishman and Baker, 2012). Often,
non-intuitive mutations are needed to
improve the folding, activity, or stability
of a protein. A major boon for FP design
is the ability to rapidly screen for func-
tion—namely, color and intensity. Similar
screening methods to look for other fea-
tures in proteins, such as enzyme activ-
ity, ligand binding, or optical qualities,
are also being combined with massive
directed evolution methods to produce
new engineered proteins with optimized
behaviors (Fleishman and Baker, 2012;
Romero and Arnold, 2009). In addition
to providing an exciting new FP, the
work presented here demonstrates the
ability of directed evolution to fill in
gaps in the collection of nature’s protein
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The goal of structural vaccinology is to enable the design and engineering of improved antigens. In a recent
issue ofChemistry & Biology, Gourlay and colleagues provided evidence that structure-based computational
methods allow prediction of B cell epitopes, a crucial step for antigen selection and optimization in vaccine
development.Understanding the molecular bases of
immune recognition is one of the big
challenges in vaccine development, andthe elucidation of the three-dimensional
(3D) structure of antigens and antigen-
antibody complexes is central to struc-tural vaccinology. This provides knowl-
edge on which structural and dynamic
properties might be responsible for the2013 Elsevier Ltd All rights reserved 1205
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Previewsability of antigens to elicit functional or
protective antibodies (Dormitzer et al.,
2008, Kulp and Schief, 2013). Although
genomic and proteomic methods, now
widely utilized, provide key information
on secreted or surface-exposed vaccine
target candidates, labor-intensive re-
search is still required for the selection
of the best vaccine antigens (Sette and
Rappuoli, 2010). This is mostly due to
the necessity of elucidating the bio-
chemical and immunological properties
of each single antigen experimentally,
which is essential in order to formulate
vaccines using themost stable and immu-
nogenic antigen configurations or con-
formations (i.e., stable molecules that
are easily recognized by the immune sys-
tem and thus able to elicit an appropriate
immune response). One of the pivotal
activities in this pipeline is the discovery
of those regions of the antigen that are
involved in forming the interface with the
antibody.
So far, understanding the properties
that control the interactions between
antigen epitopes and antibody paratopes
requires atomic-level information of their
complexes. To date, over 200 nonsimilar
antigen-antibody complex structures
have been deposited in the protein data
bank (PDB), providing a database from
which to extract conserved features of
such interactions. Several research teams
have attempted to define a series of rules
devised to explain the desirable proper-
ties of amino acids usually forming an
epitope (Kringelum et al., 2013), like the
complementarity of epitope-paratope
surfaces (Greenspan and Cooper, 1995),
the affinity and specificity of their inter-
action (Padlan et al., 1995), or the extent
to which they are exposed on the surface
(Novotny´ et al., 1986). In cases where it
is not possible to elucidate the full 3D
structure of an antigen-antibody complex,
which is a rather time consuming activity,
methods that allow the reliable and quick
identification of putative epitopes are
needed. If the 3D structure of the antigen
alone is available, it is now possible to use
its atomic coordinates for the prediction
of immunogenic regions, which can then
be used for generating optimized antigens
in the form of synthetic peptide epitopes.
In the September issue of Chemistry &
Biology, Gourlay et al. (2013) showed
that computational epitope predictions,1206 Chemistry & Biology 20, October 24, 20performed with two independent in silico
methods, were able to elucidate the
presence of an antigenic epitope, which
was then confirmed to elicit bactericidal
antibodies when presented as a synthetic
peptide. From the crystal structure of the
acute phase antigen Pal-Bp (BPSL2765)
of Burkholderia pseudomallei, originally
identified by reverse vaccinology, the au-
thors used molecular dynamics simula-
tions to select the most representative
ensemble of structures, which were suc-
cessively employed for epitope predic-
tion. This was performed by analyzing
separately physicochemical properties
of the antigen surface, such as its solva-
tion, energetics, and topology. Specif-
ically, the authors used the electrostatic
desolvation profiles (EDP) (Fiorucci and
Zacharias, 2010) and the matrix of local
coupling energies (MLCE) methods
(Scarabelli et al., 2010). Experimental
epitope mapping using polyclonal anti-
bodies was then performed by partial
digestion, immunocapture, and mass
spectrometry, and consensus models
between the epitopes found by compu-
tational and experimental methods were
built. The resulting consensus regions
of Pal-Bp were synthesized, and their
immunoreactivity to human plasma anti-
bodies, neutrophil opsonization killing,
and bacterial agglutination activities were
investigated.
A single highly immunogenic region of
Pal-Bp (EPITOPE 3) was found, and
antibodies raised against a synthetic
epitope generated around this epitope
were significantly more active (as tested
by opsonization killing using human
neutrophils and in assays of antibody-
mediated B. pseudomallei agglutination)
when compared with those generated
against the full-length recombinant pro-
tein. The authors hypothesize that this
enhanced immunogenicity could origi-
nate from a smaller recognition sequence
or from a more efficient exposure of the
peptide epitope than in the full-length
conformation. Importantly, the dissection
of fully folded antigens in subdomains
was previously explored by the same
authors (Genoni et al., 2012; Lassaux
et al., 2013) in order to overcome the
main limitation of the EDP and MLCE
methods that use the full-length 3D
folded structures to analyze their surface
physicochemical properties. Clearly, pro-13 ª2013 Elsevier Ltd All rights reservedcessing an antigen might expose regions
that, in the fully folded protein, are not
necessarily exposed or available for
recognition by antibodies.
This work confirms how a structural
understanding of the molecules involved
in immune recognition can guide vaccine
development (Dormitzer et al., 2012)
and how structure-based computational
methods are now becoming valuable
tools for extending the scope of struc-
tural vaccinology. By building on prior
knowledge of the atomic and molecular
bases of antigen-antibody recognition,
these new computational methods seem
poised to provide the tools needed for
the design of more efficacious vaccines.
For example, the generation of libraries
or databases of potential epitopes avail-
able for synthesis would revolutionize
the way antigens are presently screened
and selected for vaccine development.REFERENCES
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